CoChat

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index; 9 of the 14 sources its claims cite were checked for support.

Dynamic Halbach array magnet integrated microfluidic system for the continuous-flow separation of rare tumor cells

Open access
Xue, Mei, Xiang, An, Guo, Yanhai, Wang, Li, Wang, Rou, Wang, Wenwen, Ji, Gang, Lu, Zifan · 2019 · RSC Advances

Abstract

. Finally, the CTCs were successfully detected in 10 of 10 (100%) blood samples from patients with cancer. Therefore, the dHAMI microfluidic system could effectively isolate intact and heterogeneous CTCs for downstream cellular and molecular analyses, and this robust microfluidic platform with an excellent magnetic manipulation performance also has great application potential for the separation of other rare cells.

Overview

CoChat Summary

TL;DR

The authors developed a dynamic Halbach array magnet-integrated (dHAMI) microfluidic system for continuous-flow negative isolation of circulating tumor cells (CTCs) from whole blood. Under optimized conditions, the system achieved an average CTC capture rate of 91.6 ± 3.9% across 50–1000 spiked cancer cells per mL and detected CTCs in 10 of 10 gastric cancer patient blood samples.

Key findings

  • The dHAMI system uses a continuously moving Halbach array magnet to reduce magnetic bead aggregation and enable continuous-flow negative CTC isolation without a sample loading volume limitation.
  • At the optimal flow rate of 100 μL min−1, the average CTC capture rate over 50–1000 spiked AGS cells per mL was 91.6 ± 3.9%; capture increased from 87.0% at 50 cells per mL to 96.6% at 1000 cells per mL.
  • The optimal CD45-labelled immunomagnetic bead ratio was 20:1, giving a WBC depletion rate of 99.6 ± 0.2%; at flow rates from 100 to 200 μL min−1, WBC depletion fell from 97.7% to 91.2%.
  • In clinical samples from 10 patients with gastric cancer, CTCs were detected in 10 of 10 (100%) samples, ranging from 2 to 8 CTCs; the system processed 1 mL sample input in 10 min and had a throughput of 6 mL h−1.

Methods

  • Design: a ring-shaped PMMA microfluidic chip (channel 1 mm wide × 0.5 mm high) with two inlets and two outlets, integrated with a ring-shaped Halbach array magnet made of thirty NdFeB cubes (5 × 5 × 5 mm; ring diameter 45 mm) moved circularly at 120 rpm by a stepper motor.
  • Samples: 15 μm fluorescent polystyrene particles and CellTracker Green-labelled human gastric cancer AGS cells were spiked into whole blood; clinical validation used 3 mL whole blood from 10 patients with gastric cancer. Blood was RBC-lysed, incubated with CD45-labelled immunomagnetic beads, diluted, and injected at flow rates of 25–200 μL min−1.
  • Analysis: CTC capture rate and WBC depletion rate were calculated from fluorescence microscopy and automated cell counting; data are reported as mean ± SD from three independent experiments using GraphPad Prism 7.0.

Limitations

  • The paper states that negative isolation generally has unsatisfactory purity of isolated CTCs, which can interfere with subsequent analysis, and that future work will focus on further miniaturization and optimization of channel sizes for different rare cells.
  • Evident from the text: clinical validation was limited to 10 patients with gastric cancer, with no non-cancer clinical control cohort reported; spiking and capture-rate experiments used AGS gastric cancer cells only.
  • Evident from the text: the study reports isolation and immunofluorescent identification but does not demonstrate downstream molecular, culture, or functional analyses of the isolated CTCs.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1039/c9ra08285a

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Illustration of the dynamic Halbach array magnet integrated (dHAMI) microfluidic system. (A) Schematic diagram of the experimental procedure for CTC negative isolation using a microfluidic system with dynamic Halbach array magnet (dHAMI microfluidic system). The operation time of dHAMI microfluidic system for CTC isolation is 40 min. (B) Cell separation principle and force analysis in the microchannel of dHAMI microfluidic system. (C) Schematic illustration of microfluidic chip with sample inlet, buffer inlet, outlet 1 and outlet 2. The width of microchannel is 1 mm, and the height of microchannel is 0.5 mm. The blue arrow indicates the direction of magnetization of each permanent magnet cube.
Fig. 1 Illustration of the dynamic Halbach array magnet integrated (dHAMI) microfluidic system. (A) Schematic diagram of the experimental procedure for CTC negative isolation using a microfluidic system with dynamic Halbach array magnet (dHAMI microfluidic system). The operation time of dHAMI microfluidic system for CTC isolation is 40 min. (B) Cell separation principle and force analysis in the microchannel of dHAMI microfluidic system. (C) Schematic illustration of microfluidic chip with sample inlet, buffer inlet, outlet 1 and outlet 2. The width of microchannel is 1 mm, and the height of microchannel is 0.5 mm. The blue arrow indicates the direction of magnetization of each permanent magnet cube.CC BY-NC · PubMed Central
Fig. 2 (A) Photograph of the fabricated dHAMI microfluidic system. Scale bar is 10 mm. (B) Photograph of the workstation of dHAMI microfluidic system for CTCs isolation.
Fig. 2 (A) Photograph of the fabricated dHAMI microfluidic system. Scale bar is 10 mm. (B) Photograph of the workstation of dHAMI microfluidic system for CTCs isolation.CC BY-NC · PubMed Central
Fig. 3 Numerical simulation of the magnetic flux density of the Halbach array magnet. Magnetic field distribution of the Halbach array magnet. The contour plot is for the magnetic potentials.
Fig. 3 Numerical simulation of the magnetic flux density of the Halbach array magnet. Magnetic field distribution of the Halbach array magnet. The contour plot is for the magnetic potentials.CC BY-NC · PubMed Central
Fig. 4 Distribution of magnetic beads under Halbach array magnetic field and moving Halbach array magnetic field. Scale bar is 200 μm.
Fig. 4 Distribution of magnetic beads under Halbach array magnetic field and moving Halbach array magnetic field. Scale bar is 200 μm.CC BY-NC · PubMed Central
Fig. 5 Optimization of the separation conditions. (A) CTC capture rate and WBC depletion rate of the dHAMI microfluidic system at different flow rates. (B) WBC depletion rate of the dHAMI microfluidic system under different volumes of CD45-labelled immunomagnetic beads.
Fig. 5 Optimization of the separation conditions. (A) CTC capture rate and WBC depletion rate of the dHAMI microfluidic system at different flow rates. (B) WBC depletion rate of the dHAMI microfluidic system under different volumes of CD45-labelled immunomagnetic beads.CC BY-NC · PubMed Central
Fig. 6 Isolation CTCs from whole blood samples spiked with cancer cells. (A) CTC capture rate of the dHAMI microfluidic system from whole blood samples spiked with rare number AGS cells (50–1000 AGS cells per ml). (B) Relationship between the number of captured cancer cells and the number of spiked cancer cells (y = 0.964x − 6.363, r2 = 0.9994).
Fig. 6 Isolation CTCs from whole blood samples spiked with cancer cells. (A) CTC capture rate of the dHAMI microfluidic system from whole blood samples spiked with rare number AGS cells (50–1000 AGS cells per ml). (B) Relationship between the number of captured cancer cells and the number of spiked cancer cells (y = 0.964x − 6.363, r2 = 0.9994).CC BY-NC · PubMed Central
Fig. 7 Fluorescent images of isolated cells using the dHAMI microfluidic system from a clinical blood sample of the patient with gastric cancer. Cells stained with Hoechst positive, CD45 negative, CK positive or Hoechst positive, CD45 negative, EpCAM positive are regarded as CTCs (green arrow). Red arrow shows the WBC (Hoechst positive, CD45 positive, CK negative or EpCAM negative). Scale bar is 10 μm.
Fig. 7 Fluorescent images of isolated cells using the dHAMI microfluidic system from a clinical blood sample of the patient with gastric cancer. Cells stained with Hoechst positive, CD45 negative, CK positive or Hoechst positive, CD45 negative, EpCAM positive are regarded as CTCs (green arrow). Red arrow shows the WBC (Hoechst positive, CD45 positive, CK negative or EpCAM negative). Scale bar is 10 μm.CC BY-NC · PubMed Central

Verification

Claims the paper makes

7 Valid · 1 Not valid · 5 Not checked · 37 Own results and interpretations

23 more claims

Create a free account to see all 50 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 16
  • Probably not a substantial claim. 6
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 43 references

Cited by

Metadata

Authors
Xue, M., Xiang, A., Guo, Y., Wang, L., Wang, R., Wang, W., Ji, G., & Lu, Z.
Affiliations
  • First Affiliated Hospital of Xi'an Jiaotong University (CN)
  • Air Force Medical University (CN)
  • Xijing Hospital (CN)
Corresponding author
Lu, Zifan
Venue
RSC Advances
Published
2019
Volume
9
Issue
66
Pages
38496-38504
ISSN
2046-2069 (ISSN-L)
OpenAlex
W2990575894
Cited by
26
References
43
Citations by year
2026: 2 · 2025: 7 · 2024: 6 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 1
FWCI
0.71
Type
journal article
Language
en
Open access
Locations
  • RSC Advances (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (No.31570168, No.81301513)
  • Natural Science Foundation of Shaanxi Province (2018JM7032)
  • National Basic Research Program of China (2017YFC1308600)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
  • Physical Sciences › Physics and Astronomy › Condensed Matter Physics › Micro and Nano Robotics
Keywords
microfluidic cell separation, circulating tumor cells, rare cell isolation, magnetic manipulation, continuous-flow microfluidics, cancer detection, cellular heterogeneity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.